Note: Ingredients listed on restricted chemical lists
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
5-10
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
1-5
EC/CAS
25322-69-4
Name of the chemical
polypropyleneglycol
Concentration
5-15 -1-
General Information
Revision date
2010-02-01
Product name
IRO - Impact Resistant Outerwrap
1.2.1 Relevant identified uses
To provide impact resistant to Polyguard corrosion products
Manufacturer Name
Polyguard Products, Inc
Emergency telephone
214.515.5000
Icons in SDS
Company Information
company name
Polyguard Products, Inc
Section 2
SECTION 2: Hazards identification
A. Emergency Overview:
Appearance/Odor
Fiberglass cloth, coated with viscous resin with no odor
Potential health effects
Acute Eye: Liquid, aerosols or vapor are irritating and can cause tearing, reddening and swelling. If left untreated, corneal damage can occur and injury is slow to heal. Damage, however is usually reversible. Acute Skin: Isocyanates react with skin protein and moisture and can cause irritation which may include the following symptoms: reddening, swelling, rash, scaling or blistering. Cured material is difficult to remove. Acute Inhalation: Although MDI is low volatility, an inhalation hazard can exist from MDI aerosols or vapors formed during heating, foaming or spraying. Can irritate mucous membranes, cause runny nose, sore throat, coughing, and other symptoms. Acute ingestion: Irritation and corrosive action can occur in the mouth, stomach tissue and digestive tract. Symptoms can include: sore throat, abdominal pain, nausea, vomiting and diarrhea.
Potential chronic health
Prolonged skin contact can cause reddening, swelling, rash, scaling or blistering and in some cases, skin sensitization. Individuals who have skin sensitization can develop these symptoms from contact with liquid or vapor. Animal tests have indicated that respiratory sensitization can result from skin contact with MDI. These data reinforce the need to prevent direct skin contact with MDI.
Medical Conditions Generally Aggravated by Exposure
Asthma, other respiratory disorders (bronchitis, emphysema, bronchial hyper reactivity), skin allergies, eczema. - 2 - IV.